Pharmaceutical Companies Performance Tables 2010
Pharmaceutical Company Performance TablesThe answers to thousands of key questions are in the new 2010 editionIn today's challenging market, business planners and commercial management must ask themselves some key questions, such as...Who are the winners and losers in terms of revenue growth' Which companies have succeeded in maintaining or growing profits' Overall R&D investment from the top 10 companies fell between 2008 and 2009 by US$421 million from US$57.54 billion to US$57.12 billion ' yet some companies maintained or expanded R&D spend. Who were they' Who are the fastest growers' 10 companies with joint 2005 sales of US$2.55 billion posted sales of $US13.06 billion in 2009. Who were they' Which companies are cash rich or cash poor' Pharmaceutical Company Performance TablesThe answers to thousands of key questions are in the new 2010 editionThis essential fully-updated business reference report compares and contrasts the performance and fortunes of leading pharmaceutical companies and places them in easy-to-read tables. Importantly, in addition to rankings, the new edition of the report includes the individual results for 162 companies and up to five years of key data from the balance sheet, income statement and cash flow. Key Facts & Benefits of this report:Full 2009 year-end figures Contains a wide range of detailed performance rankings for more than 160 leading pharmaceutical companies Includes individual company results Provides up to five years of trend data Available in print or pdf with web access included free of charge!Trends affecting the global industry The challenging economic environment continues to affect health spending in many countries which has impacted the pharmaceutical industry's commercial performance. Issues which are affecting companies' performance, include...The number of blockbuster drugs which have lost patent protection, and the number is set to rise over the coming years, have not been replaced by new products offering significant therapeutic advances Those products which have been launched ' increasingly in the biological area ' have attracted criticism and objection from health payers due to their high costMany companies continue to post rising revenues and increasing profits, although for many it is against a background of cost cutting Mergers and acquisitions, and especially technology/product acquisition, have taken an increasing role in market entry/expansion plansGeneric competition continues to erode the profits of off-patent products, although spending constraints and rising competition are creating pressure in the generic sector.Pharmaceutical Companies Performance TablesA unique opportunity to assess companies' financial and operating performances. Use it for... Competitor analysis Acquisition targeting Partnering and licensing background PR and Marketing Performance benchmarking Just some of the 162 companies in the 2010 edition... Abbott Laboratories Abraxis BioScience Ajinomoto Alcon Laboratories Allergan Amgen Amylin Pharmaceuticals Astellas AstraZeneca Baxter International Bayer Biogen Idec Boehringer Ingelheim Bristol-Myers Squibb BTG International Celgene Chugai CSL Limited Cubist Pharmaceuticals Cytokinetics Daiichi Sankyo Dainippon Sumitomo Pharma Dendreon Dr Reddy's Labs Egis Eisai Elan Eli Lilly Endo Pharmaceuticals Enzon Pharmaceuticals Eurand Forest Laboratories Gedeon Richter Genzyme Gilead Sciences GlaxoSmithKline Hospira Human Genome Sciences ImmunoGen Incyte Inspire Pharmaceuticals Ipsen Isis Pharmaceuticals Johnson & Johnson KRKA Kyowa Kirin Lundbeck Mannkind Merck & Co Merck KGaA Mitsubishi Tanabe Pharma Mylan Laboratories Nipro Novartis Novo Nordisk NPS Pharmaceuticals Nycomed Ono Pharmaceuticals Orion OSI Pharmaceuticals Otsuka Pfizer Procter & Gamble Ranbaxy Recordati Regeneron Pharmaceuticals Roche sanofi-aventis Sawai Shionogi Shire Pharmaceuticals Stada Arzneimittel Takeda Teva Pharmaceutical Industries Theravance UCB Vertex Pharmaceuticals XOMA ZymoGene
Empfohlen
Empfohlen
Weitere ähnliche Inhalte
Mehr von ReportLinker.com
Mehr von ReportLinker.com (20)
Kürzlich hochgeladen
Kürzlich hochgeladen (20)
Pharmaceutical Companies Performance Tables 2010
- 1. Find Industry reports, Company profiles ReportLinker and Market Statistics >> Get this Report Now by email! Pharmaceutical Companies Performance Tables 2010 Published on January 2011 Report Summary Pharmaceutical Company Performance Tables The answers to thousands of key questions are in the new 2010 edition In today's challenging market, business planners and commercial management must ask themselves some key questions, such as... Who are the winners and losers in terms of revenue growth' Which companies have succeeded in maintaining or growing profits' Overall R&D investment from the top 10 companies fell between 2008 and 2009 by US$421 million from US$57.54 billion to US$57.12 billion ' yet some companies maintained or expanded R&D spend. Who were they' Who are the fastest growers' 10 companies with joint 2005 sales of US$2.55 billion posted sales of $US13.06 billion in 2009. Who were they' Which companies are cash rich or cash poor' Pharmaceutical Company Performance Tables The answers to thousands of key questions are in the new 2010 edition This essential fully-updated business reference report compares and contrasts the performance and fortunes of leading pharmaceutical companies and places them in easy-to-read tables. Importantly, in addition to rankings, the new edition of the report includes the individual results for 162 companies and up to five years of key data from the balance sheet, income statement and cash flow. Key Facts & Benefits of this report: Full 2009 year-end figures Contains a wide range of detailed performance rankings for more than 160 leading pharmaceutical companies Includes individual company results Provides up to five years of trend data Available in print or pdf with web access included free of charge! Trends affecting the global industry The challenging economic environment continues to affect health spending in many countries which has impacted the pharmaceutical industry's commercial performance. Issues which are affecting companies' performance, include... Pharmaceutical Companies Performance Tables 2010 Page 1/10
- 2. Find Industry reports, Company profiles ReportLinker and Market Statistics The number of blockbuster drugs which have lost patent protection, and the number is set to rise over the coming years, have not been replaced by new products offering significant therapeutic advances Those products which have been launched ' increasingly in the biological area ' have attracted criticism and objection from health payers due to their high cost Many companies continue to post rising revenues and increasing profits, although for many it is against a background of cost cutting Mergers and acquisitions, and especially technology/product acquisition, have taken an increasing role in market entry/expansion plans Generic competition continues to erode the profits of off-patent products, although spending constraints and rising competition are creating pressure in the generic sector. Pharmaceutical Companies Performance Tables A unique opportunity to assess companies' financial and operating performances. Use it for... Competitor analysis Acquisition targeting Partnering and licensing background PR and Marketing Performance benchmarking Just some of the 162 companies in the 2010 edition... Abbott Laboratories Abraxis BioScience Ajinomoto Alcon Laboratories Allergan Amgen Amylin Pharmaceuticals Astellas AstraZeneca Baxter International Bayer Biogen Idec Boehringer Ingelheim Bristol-Myers Squibb BTG International Celgene Chugai CSL Limited Cubist Pharmaceuticals Cytokinetics Daiichi Sankyo Dainippon Sumitomo Pharma Dendreon Dr Reddy's Labs Pharmaceutical Companies Performance Tables 2010 Page 2/10
- 3. Find Industry reports, Company profiles ReportLinker and Market Statistics Egis Eisai Elan Eli Lilly Endo Pharmaceuticals Enzon Pharmaceuticals Eurand Forest Laboratories Gedeon Richter Genzyme Gilead Sciences GlaxoSmithKline Hospira Human Genome Sciences ImmunoGen Incyte Inspire Pharmaceuticals Ipsen Isis Pharmaceuticals Johnson & Johnson KRKA Kyowa Kirin Lundbeck Mannkind Merck & Co Merck KGaA Mitsubishi Tanabe Pharma Mylan Laboratories Nipro Novartis Novo Nordisk NPS Pharmaceuticals Nycomed Ono Pharmaceuticals Orion OSI Pharmaceuticals Otsuka Pfizer Procter & Gamble Ranbaxy Recordati Regeneron Pharmaceuticals Roche sanofi-aventis Sawai Shionogi Shire Pharmaceuticals Stada Arzneimittel Takeda Teva Pharmaceutical Industries Pharmaceutical Companies Performance Tables 2010 Page 3/10
- 4. Find Industry reports, Company profiles ReportLinker and Market Statistics Theravance UCB Vertex Pharmaceuticals XOMA ZymoGenetics Extensive Contents Key Financial Indicators include: Pharmaceutical Sales Total Revenues Cost of Sales Operating Income Net Income Earnings per Share R&D Expenditure Capital Expenditure Return on Capital Employed Total Assets Cash in Hand Employees Companies are also ranked by: Productivity Profitability Research Rates Investment Rates Performance Indicators: (Using Pharmaceutical Sales as an example) Companies by Pharmaceutical Sales 2005-2009 (US$m) Companies by Yearly Change (Local Currency) Companies by Five-Year Change (Local Currency) Five-Year Movement of Pharmaceutical Sales (2000 constant US$ Exchange Rates) Five-Year Change in Pharmaceutical Sales (Index Numbers) Table of Content Who are the Winners in the Global Pharmaceutical Industry' Pharmaceutical Companies Performance Tables 2010 Company List Abbott Laboratories Abraxis Bioscience Affymax Ajinomoto Pharmaceutical Companies Performance Tables 2010 Page 4/10
- 5. Find Industry reports, Company profiles ReportLinker and Market Statistics Alcon Laboratories Alexion Pharmaceuticals Alkermes Allergan Allos Therapeutics Alnylam Pharmaceuticals American Oriental Bioengineering Amgen Amicus Therapeutics Amylin Pharmaceuticals Angiotech Arena Pharmaceuticals Asahi Kasei Astellas AstraZeneca Axcan Pharma Baxter International Bayer Biogen Idec Biomarin Pharmaceuticals Biotest Biovail Boehringer Ingelheim Bristol-Myers Squibb BTG International Cadence Pharmaceuticals 2 Cangene Caraco Pharmaceutical Laboratories Celgene Cephalon Cerus Chugai Columbia Laboratories Crucell CSL Limited Cubist Pharmaceuticals Cypress Bioscience Cytokinetics Daiichi Sankyo Dainippon Sumitomo Pharma Dendreon Discovery Laboratories Dr Reddys Durect Dyax Corporation Egis Eisai Elan Corporation Pharmaceutical Companies Performance Tables 2010 Page 5/10
- 6. Find Industry reports, Company profiles ReportLinker and Market Statistics Eli Lilly Emergent Biosolution Endo Pharmaceuticals Enzon Pharmaceuticals Eurand NV Evotek AG Exelixis Forest Laboratories Gedeon Richter Genzyme Gilead Sciences GlaxoSmithKline GTx Hospira Human Genome Sciences Idenix Idera Immunogen Incyte Inspire Pharmaceuticals Intermune Ipsen 3 Isis Pharmaceuticals Johnson & Johnson King Pharmaceuticals Kissei Pharmaceutical KRKA Kyowa Kirin Lexicon Pharmaceuticals Ligand Pharmaceuticals Lundbeck Mannkind MAP Pharmaceuticals Martek Biosciences Medicis Pharmaceutical Corporation Merck & Co Merck KGaA Micromet Mitsubishi Tanabe Pharma Molecular Insight Momenta Mylan Laboratories Nabi Biopharmaceuticals Nektar Therapeutics Neurocrine Biosciences Nippon Shinyaku Nipro Novartis Pharmaceutical Companies Performance Tables 2010 Page 6/10
- 7. Find Industry reports, Company profiles ReportLinker and Market Statistics Novo Nordisk NPS Pharmaceuticals Nycomed Ono Pharmaceuticals Onyx Optimer Orexigen Orion OSI Pharmaceuticals Osiris Therapeutics Otsuka Pain Therapeutics Paladin Labs Par Pfizer Pharmasset Pharmaxis Poniard Pharmaceuticals 4 Procter and Gamble Progenics QLT Questcor Ranbaxy Recordati Regeneron Repligen Rigel Pharmaceuticals Roche Salix Pharmaceuticals sanofi-aventis Santen Savient Pharmaceuticals Sawai Sciclone Seattle Genetics Seikagaku Shionogi Shire Pharmaceuticals Simcere Stada Arzneimittel Sucampo Pharmaceuticals Sumitomo Chemical Supergen Taisho Takeda Teijin Teva Pharmaceutical Industries The Medicines Company Theravance Pharmaceutical Companies Performance Tables 2010 Page 7/10
- 8. Find Industry reports, Company profiles ReportLinker and Market Statistics Trimeris UCB United Therapeutics Valeant Pharmaceuticals Vectura Vertex Pharmaceuticals ViroPharma Vivus Warner Chilcott Watson Pharmaceuticals XenoPort Xoma ZymoGenetics Pharmaceutical Companies Performance Tables 2010 Page 8/10
- 9. Find Industry reports, Company profiles ReportLinker and Market Statistics Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93 If you have any questions please visit http://www.reportlinker.com/notify/contact Order Information Please verify that the product information is correct and select the format(s) you require. Pharmaceutical Companies Performance Tables 2010 Product Formats Please select the product formats and the quantity you require. 1 User License--USD 866.25 Quantity: _____ Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: _____________________________ Last Name: __________________________________ Email Address: __________________________________________________________________________ Job Title: __________________________________________________________________________ Organization: __________________________________________________________________________ Address: __________________________________________________________________________ City: __________________________________________________________________________ Postal / Zip Code: __________________________________________________________________________ Country: __________________________________________________________________________ Phone Number: __________________________________________________________________________ Fax Number: __________________________________________________________________________ Pharmaceutical Companies Performance Tables 2010 Page 9/10
- 10. Find Industry reports, Company profiles ReportLinker and Market Statistics Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box. Payment by credit card Card Number: ______________________________________________ Expiry Date __________ / _________ CVV Number _____________________ Card Type (ex: Visa, Amex…) _________________________________ Payment by wire transfer Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189 Payment by check UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE Customer signature: Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93 Pharmaceutical Companies Performance Tables 2010 Page 10/10